Trump Admin Moves Medical Cannabis to Schedule III
In a decisive move that marks the most significant alteration in federal drug policy since the 1970s, the Trump administration has officially reclassified state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III under the Controlled Substances Act. This action, spearheaded by Acting Attorney General Todd Blanche, delivers on the directives outlined…

